Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › NEULANDLAB

NEULANDLAB

Neuland Laboratories Limited
Small-capHealthcare ↗

What the six lenses say about NEULANDLAB — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹22870.0
2026-09-08
VWAP · 1Y anchor
₹16864
+35.6% from VWAP
P/E · TTM
80.6×
TTM EPS ₹283.7
52-week range
93%
position low→high
RSI(14)
58
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How NEULANDLAB’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD890›

The actual numbers

Price vs VWAP (1y)+35.6%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+31.3%
Price vs 50-EMA+8.3%
RSI(14)58
RS vs Nifty 500 · 3M+30.4%
RS vs sector · 3M+27.7%
52-week range93%
Volume vs 30d avg0.92×
Volume vs 60d avg1.24×
ATR(14) · volatility786.3
Bollinger width · vol contraction0.053
FundamentalD1090›

The actual numbers

Return on equity (ROE)21.4%
Return on capital (ROCE)26.6%
Operating margin25.3%
Net margin18.0%
Revenue growth · YoY+37.0%
EPS growth · YoY+39.9%
Debt / equity0.16×

Full 8-quarter history in the financials table below.

ValuationD10›

The actual numbers

P/E (TTM)80.6×
TTM EPS₹283.7
52-week range93%
CatalystD744›

The actual numbers

Earnings & momentum49
Capital actions10
Governance93

Every filing in the corporate-announcements panel below.

FlowD242›

The actual numbers

Promoter holding32.6%
Delivery · 30d avg44.8%
Up/down-day asymmetry-5.6pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D8 + D2 ) ÷ 2 = 5.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
85
Conviction score 85/100 · avg-decile strength 5.0/10
Conviction score85/100›
TechnicalD8›
FundamentalD10›
ValuationD1›
CatalystD7›
FlowD2›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+1.4pp
+0.6pp
+9.6pp
+32.0pp
+78.2pp
+62.3pp
Nifty 500
Broad-market baseline
+1.3pp
+0.6pp
+8.6pp
+30.4pp
+72.5pp
+57.1pp
Sector
Own-sector index
—
—
+7.2pp
+27.7pp
+63.8pp
+43.8pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

NEULANDLAB daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
22870.00+210.00

Relative strength

RS vs baseline · rebased to 100

NEULANDLAB ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
183.64+2.45

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)440311398328293514440776
↳ change QoQ—-29.3%+28.0%-17.6%-10.7%+75.4%-14.4%+76.4%
EBITDA (₹cr)14967146513415677307
EBITDA margin33.9%21.4%36.8%15.6%11.6%30.3%17.5%39.6%
PAT (₹cr)983310228149741213
↳ change QoQ—-66.4%+209.3%-72.4%-50.0%+592.9%-57.7%+419.5%
Net margin22.3%10.6%25.5%8.5%4.8%18.9%9.3%27.5%
EPS (₹)76.2825.6079.1821.6810.8375.4931.62165.76
D/E————————
YoY growth · Mar '26Revenue +136.6% YoYPAT +660.7% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Sep '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 Aug '26
    MEDIUMcapital
    Credit Rating
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 14 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Capacity addition
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Giving guarantees/indemnity/ becoming a surety for third party
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 5 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 5 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 31 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Jul '26
    MEDIUMcapital
    Credit Rating
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds NEULANDLAB

Mutual funds holding NEULANDLAB (10)

FundWeightAUM ₹crGrade
ICICI Pru Flexicap Reg Gr1.78%24,100
HSBC Small Cap Fund Reg Gr1.73%17,784
WhiteOak Capital Flexi Cap Reg Gr0.55%9,136
Bajaj Finserv Flexi Cap Reg Gr1.88%8,173
Mahindra Manulife Multi Cap Reg Gr3.53%7,184
Edelweiss Small Cap Reg Gr0.90%6,825
HSBC Multi Cap Reg Gr1.16%6,068
PGIM India Flexi Cap Reg Gr0.83%5,898
Mirae Asset Small Cap Reg Gr1.95%5,221
Mahindra Manulife Small Cap Reg Gr3.87%5,087

ETFs holding NEULANDLAB (8)

ETFWeightGrade
Zerodha Nifty Smallcap 100 ETF1.39%
Mirae Asset Nifty 500 Healthcare ETF1.17%
Motilal Oswal BSE Healthcare ETF1.01%
DSP Nifty Smallcap 250 ETF0.79%
HDFC Nifty Smallcap 250 ETF0.76%
Mirae Asset Nifty Smallcap 250 ETF0.76%
Motilal Oswal Nifty Smallcap 250 ETF0.76%
Groww Nifty Smallcap 250 ETF0.76%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare